Clinical Indicators and Preventive Care

Clinical Indicators and Preventive Care

Dialysis adequacy 100% (KDOQI target) 100% (KDOQI target) Vascular access 100% (KDOQI target) 50% (KDOQI target) Anemia mgmt Diabetic care Vacc...

5MB Sizes 0 Downloads 83 Views

Dialysis adequacy 100% (KDOQI target)

100% (KDOQI target)

Vascular access 100% (KDOQI target)

50% (KDOQI target)

Anemia mgmt

Diabetic care

Vaccinations

90%

90%

90%

90% (HP2020 target)

18.8% (2009)

51.8% (2009)

58.1% (2009)

17% (2009)

64.3% (2009)

Pts w/hb >12 g/dl

DM pts w/4+ A1c tests

DM pts w/2+ lipid tests

DM pts w/ comp. DM mon.

ESRD pts w/ 1 flu vaccin.

55.0% (2008) 50% (KDOQI target)

93.4% (2008)

94% (2009)

87.1% (2009)

30.8% (2008)

HD pts with delivered Kt/V ≥1.2

HD pts w/ URR ≥65%

CAPD pts with delivered Kt/V ≥1.7

New pts w/AV fistula as first access

77.2% (2009) Prev. pts w/ AVF as current access

Pts w/hb 10-12 g/dl

4.1% (2009) Pts w/hb <10 g/dl

25.8% (20082009) ESRD pts w/1 pneumonia vaccin.

22.1% (2009) ESRD pts w/1 hep B vaccin.

13+ Hemoglobin (g/dl)

>12-<13

60 40 9-<10 <9

20

Hemoglobin EPO

11

15

10

10

10-<11

0 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09

Hemoglobin (g/dl)

13 2005 2001

12

2009

11

1997 10 9 8 1

2

3

4

5

6

Mean wkly EPO dose (1,000s of units)

9 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09

5

30 25 2009

2005

20 2001

15

1997

10 5 1

2

3

4

5

6

Months after initiation

Months after initiation

50

50 6 months

40 30

4-<6

20 10

2-<4

Percent of patients

20

11-12

Percent of patients

Percent of patients

80

12

Mean weekly EPO dose (1,000s of units)

100

40 30

2,700+ 1,200-<2,100 2,100-<2,700

20 0-<1,200 mg 10

0-<2 0

0 00 01 02 03 04 05 06 07 08 09

00 01 02 03 04 05 06 07 08 09

100

100

80 60 40 20

3 tests 2 tests 1 test

4+ tests Percent of patients

Percent of patients

4+ tests 80

3 tests 60 2 tests 40 1 test 20

% with comprehensive monitoring

No tests

No tests

0

0

96-97 98-99 00-01 02-03 04-05 06-07 08-09

96-97 98-99 00-01 02-03 04-05 06-07 08-09

20

15

10

5

0 96-97 98-99 00-01 02-03 04-05 06-07 08-09

80

Percent of patients

Catheter

60 AV fistula Catheter w/maturing fistula

40

AV graft Catheter w/maturing graft

20

0 2005

2006

2007

2008

2009

80

Dialysis All White African American Asian Other Hispanic

60

Percent of patients

40

20

0 80

Transplant

60

40

20

0 A

B

C

D

E

F

G

H

I

Percent of patients

60

Dialysis

Transplant All White African American Asian Other Hispanic

40

20

0 A

C

D

E

F

Dialysis

A

B

C

D

E

F

Transplant

100

All White African American Asian Other Hispanic

10

5

Percent of patients

Percent of patients

15

B

0

Percent of patients

80

Dialysis

Calcitriol Paricalcitol Inactivated Doxercalciferol vitamin D

Transplant All White African American Asian Other Hispanic

60 40 20 0 A

B

C

D

E

F

G

A

B

C

D

E

F

G

Asian Other Hispanic

60 40 20 0

Calcitriol Paricalcitol Inactivated Doxercalciferol vitamin D

All White Af Am

80

Any

Sev- Calcium Lanth- Comb. ≥1 elemer acetate anum month